Dr. Michelle Therese Fabian, MD

Dr. Fabian practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Fabian's NPI, 1043450133, was assigned on March 2, 2009. Dr. Fabian graduated from Cleveland Medical College, Homeopathic in 2005. Dr. Fabian holds New York license 249537.

Dr. Fabian's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121. Dr. Fabian also practices at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.

Dr. Fabian's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Fabian is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Fabian to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fabian practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fabian's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fabian is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fabian's licenses on file in 2 states: New York and Florida.

Dmand AI lists lower back pain and multiple sclerosis among the conditions Dr. Fabian treats.

CMS data shows 282 Medicare services from Dr. Fabian across 4 procedure codes in 2024, for 106 Medicare patients. Medicare paid $21,875 for them.

CMS counts 106 Medicare patients who saw Dr. Fabian in 2024. The largest group is 65 to 74, with 43 patients. 68% of them have high cholesterol, and 56% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fabian's median patient age at 49, with 73% women.

In 2024, Dr. Fabian wrote 380 Medicare Part D claims for 67 patients. 83% of them were for generic drugs. CMS names the drug for 212 of them, across 8 drugs with 11 or more claims each, at $325,020 in total drug cost. In 2023, CMS named 169 claims across 6 drugs.

Dr. Fabian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fabian as offering telehealth.

Dmand AI links 35 papers to Dr. Fabian, published from 2015 to 2023. 2020 was the busiest year, with 8. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Multiple Sclerosis, Chronic Progressive. Dr. Fabian has published most often in Mult Scler. Dr. Fabian's most frequent co-authors are Fred Lublin, MD, Sylvia Klineova, MD and Claire Sebastian Riley, MD.

Dmand AI links Dr. Fabian to 2 clinical trials. Conditions studied include Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Demyelinating Autoimmune Diseases, CNS.

CMS Open Payments shows 15 general payments to Dr. Fabian from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Biogen, Inc. paid the most, $1,822.

Dr. Fabian graduated from Cleveland Medical College, Homeopathic in 2005.

Dr. Fabian is in network with 16 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.